We write a great deal here about obesity care. That phrase reflects the fact that obesity is a complex chronic disease typically requiring lifelong care. Not just a simple weight loss intervention. But most of the world is not thinking in those terms. And the research symposium last week at NIH gave us an excellent perspective on why this is so. Moving beyond weight loss to sustainable obesity care will require filling in some huge research gaps to inform clinical decision making.

Put simply, we know we have some very effective obesity medicines that can help a person with obesity reduce their weight, maintain it, and improve their health in the process.  But we yet don’t know the best paths to follow for long-term obesity care. We are barely scratching at the surface

It is not as simple as just keep taking this medicine forever and call me if you run into problems.

Unanswered Questions

The core goal of the symposium, outlined by Craig Hales’ opening, was to discuss and design clinical-research strategies to produce needed evidence. We need that evidence to guide individual, long-term obesity-care plans. The point is to help patients and providers make good decisions about what is best beyond an initial phase of losing weight. Hales explained:

“Highly effective medical treatment of obesity is still in its infancy. We’re still learning how to translate short-term success into durable life-long health benefits.

“Decisions around long-term treatment are influenced by many real-world factors. These include inadequate insurance coverage, high medication cost, side effects, as well as patients’ and clinicians’ own beliefs and preferences. Meanwhile, patients and clinicians confront a growing mix of news stories, expert commentaries, and commercial programs. Some are evidence based, others are driven by anecdote, opinion, or marketing.”

It’s clear that the evidence to support long-term care decisions is thin. Five hours of presentations made this unmistakeable. But speakers and panelists, starting with Obesity Society past president Dan Bessesen, put all the big questions on the table. Does everyone need to take lifelong obesity medicine therapy? How do we best combine other tools for care? What is driving people to stop taking medicines? How can evidence inform the need to tailor individual care plans? How is stigma at work in patterns of care?

These are but a few of the questions. To wrap your head around all of them, we urge you to watch the video embedded above in our post today, or click here to go to the NIH website for this excellent symposium. You can also find the agenda for the day here.

The Waving Surface of the Autumn Flood, ink and wash painting by Ma Yuan / WikiArt